Comparison between endoscopic mucosal resection with a cap and endoscopic submucosal dissection for rectal neuroendocrine tumors

BMC Surg. 2022 Jun 27;22(1):248. doi: 10.1186/s12893-022-01693-x.

Abstract

Background: The aim of this study is to evaluate and compare the safety and efficacy of endoscopic mucosal resection with a cap (EMR-c) with those of endoscopic submucosal dissection (ESD) for rectal neuroendocrine tumors (R-NETs) ≤ 15 mm in diameter, and to analyze the risk factors of incomplete resection.

Methods: A total of 122 patients who underwent EMR-c or ESD for R-NETs at the Fourth Hospital of Hebei Medical University between February 2007 and December 2020 were invovled in this study. The clinical outcomes of two groups were compared and evaluated.

Results: A total of 122 patients with 128 R-NETs underwent endoscopic resection (EMR-c, 80; ESD, 48). In terms of duration of operation, EMR-c was significantly shorter than ESD (p < 0.001). Univariate analysis and multivariate analysis suggested that tumor diameter ≥ 8 mm was an independent risk factor for incomplete resection in patients with R-NETs in this study.

Conclusions: Both EMR-c and ESD were safe and effective treatments for R-NETs ≤ 15 mm in diameter. In addition, tumor diameter ≥ 8 mm was an independent risk factor for incomplete resection.

Keywords: Endoscopic mucosal resection with a cap; Endoscopic submucosal dissection; Incomplete resection; Rectal neuroendocrine tumor.

MeSH terms

  • Endoscopic Mucosal Resection*
  • Humans
  • Intestinal Mucosa / pathology
  • Intestinal Mucosa / surgery
  • Neuroendocrine Tumors* / pathology
  • Neuroendocrine Tumors* / surgery
  • Rectal Neoplasms* / pathology
  • Retrospective Studies
  • Treatment Outcome